Interview: David Kim Talks about the Tufts Cost-Effectiveness Analyzer (CEA) Registry

Assistant professor David Kim speaks with Rachel Breslau about his role as program director of the Tufts cost-effectiveness analyzer (CEA) registry in a new Center for the Evaluation of Value and Risk in Health (CEVR) interview. In the interview, Kim speaks about his path into the health economic and outcomes research field, the background of the CEA registry, and how he hopes to make it more accessible for patients.

According to Kim, “For a lay person interested in the value of a new Alzheimer’s drug, for example, there is probably too much technical jargon, along with other barriers, in the Registry right now to use it to answer that question. Our team is currently undergoing a major redesign of the Registry focusing on enhancing usability with better data visualizations and summary statistics and on improving the quality and efficiency of the data collection process. I hope that the Registry becomes a go-to source to identify the value-for-money evidence for anyone who thinks about how to best use our limited resources.

Read the entire interview by clicking here.

(Source: CEVR, January 20^th, 2022)